NCT05910424

Brief Summary

The goals of this pilot study are to assess the presence of harmful germs for gums and to assess oral health in adults with autism spectrum disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

November 22, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2024

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

June 7, 2023

Last Update Submit

August 22, 2024

Conditions

Keywords

Autism Spectrum DisorderOral microbiotaOral Health

Outcome Measures

Primary Outcomes (1)

  • Presence of periodontopathogenic bacteria (harmful for gums)

    Technique used = Polymerase Chain Reaction (PCR) Measure unit = Colony-Forming Unit (CFU)

    Collection on Day 1

Secondary Outcomes (5)

  • Assessment of the presence of parasites Entamoeba gingivalis subtype 1 (ST1) and subtype 2 (ST2) and Trichomonas tenax

    Collection on Day 1

  • Assessment of the periodontal status of patients with Autism Spectrum Disorder

    Day 1

  • Assessment of the dental condition

    Day 1

  • Assessment of oral hygiene

    Day 1

  • Collection of data about lifestyle habits (oral and dental hygiene, diet, activity, etc.) and drug treatments that may influence the clinical parameters observed

    Before samples collection and clinical examination

Study Arms (1)

Adults with Autism Spectrum Disorder

EXPERIMENTAL

* Adults with autism spectrum disorder * Aged between 18 and 60 years old * Dental cares and follow-up in Nancy hospital

Other: collection of saliva, gum fluid and/or dental plaque samples

Interventions

Non-invasive sampling of dental plaque, crevicular fluid and/or saliva, using an examination probe, paper tips and saliva swabs

Adults with Autism Spectrum Disorder

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • A person (or legal representative) who has received full information about the organisation of the research and accept to participate and the use of his or her data.
  • Adult with autism spectrum disorder, men or women aged between 18 and 60.
  • Member of a social security scheme or beneficiary of a medical insurance

You may not qualify if:

  • Children under 18 with autism spectrum disorder
  • Use of medication or situations that may affect the microbiota (use of antibiotics, probiotics, steroidal or non-steroidal anti-inflammatory drugs in the last 3 months, strict mouth breathing)
  • Smoking
  • Very lingual position of the teeth hindering clinical assessment of the periodontium
  • Patients who have had periodontal treatment for less than 6 months
  • Persons covered by articles L. 1121-5 to L. 1121-7 and L1122-2 of the French Public Health Code:
  • Pregnant women, women in labour or breast-feeding mothers
  • Persons deprived of their liberty by a judicial or administrative decision
  • Persons unable to give their consent
  • Person under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code
  • Minor (not emancipated)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Brabois

Vandœuvre-lès-Nancy, 54500, France

Location

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Ludivine BERBE

    CHRU Nancy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No Treatment
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Pilot study concerning adults with autism spectrum disorder
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dentist, University Hospital Assistant

Study Record Dates

First Submitted

June 7, 2023

First Posted

June 18, 2023

Study Start

November 22, 2023

Primary Completion

April 9, 2024

Study Completion

April 30, 2024

Last Updated

August 26, 2024

Record last verified: 2024-08

Locations